OD-101

N/A

Report date: 2025/06/11 10:55:16
NME

Base Information

Drug NameOD-101
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase RIPK2 inhibitors
TargetsSerine/threonine-protein kinase RIPK2
Therapy Area/IndicationsAutoimmune DiseasesJoint Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOdyssey Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesJoint Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A